Found: 14
Select item for more details and to access through your institution.
Risk factors for anti‐drug antibody formation to infliximab: Secondary analyses of a randomised controlled trial.
- Published in:
- Journal of Internal Medicine, 2022, v. 292, n. 3, p. 477, doi. 10.1111/joim.13495
- By:
- Publication type:
- Article
Adalimumab serum levels and anti-drug antibodies: associations to treatment response and drug survival in inflammatory joint diseases.
- Published in:
- Rheumatology, 2024, v. 63, n. 6, p. 1746, doi. 10.1093/rheumatology/kead525
- By:
- Publication type:
- Article
Assessing Immunogenicity of Biologic Drugs in Inflammatory Joint Diseases: Progress Towards Personalized Medicine.
- Published in:
- BioDrugs, 2022, v. 36, n. 6, p. 731, doi. 10.1007/s40259-022-00559-1
- By:
- Publication type:
- Article
The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study.
- Published in:
- BMC Medicine, 2022, v. 20, n. 1, p. 1, doi. 10.1186/s12916-022-02587-8
- By:
- Publication type:
- Article
HLA‐DQ2 is associated with anti‐drug antibody formation to infliximab in patients with immune‐mediated inflammatory diseases.
- Published in:
- Journal of Internal Medicine, 2023, v. 293, n. 5, p. 648, doi. 10.1111/joim.13616
- By:
- Publication type:
- Article
Associations between certolizumab pegol serum levels, anti-drug antibodies and treatment response in patients with inflammatory joint diseases: data from the NOR-DMARD study.
- Published in:
- Arthritis Research & Therapy, 2019, v. 21, n. 1, p. N.PAG, doi. 10.1186/s13075-019-2009-5
- By:
- Publication type:
- Article
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Maintenance Infliximab Therapy on Disease Control in Patients With Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effect of Therapeutic Drug Monitoring vs Standard Therapy During Infliximab Induction on Disease Remission in Patients With Chronic Immune-Mediated Inflammatory Diseases: A Randomized Clinical Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study.
- Published in:
- Frontiers in Immunology, 2024, p. 01, doi. 10.3389/fimmu.2024.1296273
- By:
- Publication type:
- Article
Immune complexes, innate immunity, and NETosis in ChAdOx1 vaccine-induced thrombocytopenia.
- Published in:
- European Heart Journal, 2021, v. 42, n. 39, p. 4064, doi. 10.1093/eurheartj/ehab506
- By:
- Publication type:
- Article
The effect of infliximab in patients with chronic low back pain and Modic changes (the BackToBasic study): study protocol of a randomized, double blind, placebo-controlled, multicenter trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
KRISTIN HOLSTAD.
- Published in:
- Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2021, v. 141, n. 11, p. 1108
- By:
- Publication type:
- Article
Biotilsvarende legemidler - like gode, mye billigere.
- Published in:
- Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2019, v. 139, n. 6, p. 496
- By:
- Publication type:
- Article
LENE CECILIE MATHISEN.
- Published in:
- Journal of the Norwegian Medical Association / Tidsskrift for Den Norske Laegeforening, 2018, v. 138, n. 6, p. 588
- By:
- Publication type:
- Article